Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
285M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
231M
-
Shares change
-
-1.47M
-
Total reported value, excl. options
-
$579M
-
Value change
-
-$3.89M
-
Put/Call ratio
-
5.97
-
Number of buys
-
72
-
Number of sells
-
-51
-
Price
-
$2.51
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q4 2024
160 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q4 2024.
Erasca, Inc. - Common Stock (ERAS) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 231M shares
of 285M outstanding shares and own 81.03% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (19.4M shares), T. Rowe Price Investment Management, Inc. (16.7M shares), VR Adviser, LLC (16.2M shares), BlackRock, Inc. (15.8M shares), VANGUARD GROUP INC (12.7M shares), Logos Global Management LP (12.5M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (12.3M shares), ARCH Venture Management, LLC (11.1M shares), Paradigm Biocapital Advisors LP (10.8M shares), and Siren, L.L.C. (8.86M shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.